|
|||||
|
|
Final 192‐week efficacy and safety of once‐daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV‐1‐infected treatment‐naïve patients in the ARTEMIS trial |
|
| Authors: | C Orkin E DeJesus H Khanlou A Stoehr K Supparatpinyo E Lathouwers E Lefebvre M Opsomer T Van de Casteele F Tomaka |
| Affiliation: | 1. Barts and The London NHS Trust, , London, UK;2. Orlando Immunology Center, , Orlando, FL, USA;3. AIDS Healthcare Foundation, , Los Angeles, CA, USA;4. Institute for Interdisciplinary Medicine, , Hamburg, Germany;5. Chiang Mai University, , Chiang Mai, Thailand;6. Tibotec BVBA, , Beerse, Belgium;7. Janssen, , Tilburg, the Netherlands;8. Tibotec Inc., , Titusville, NJ, USA |
| Abstract: | |
| Keywords: | darunavir efficacy lopinavir safety treatment‐naï ve |